15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 7 firms covering LivaNova PLC, 5 rate it Buy or better, 2 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $70.00 to $95.00, so the covering firms are broadly aligned. The average target of $81.57 sits 1% below the current $82.05. The rating mix has stayed broadly stable, with Buy-side ratings easing from 6 to 5 over recent months. On the fundamentals, the Street sees consensus EPS building from about $1.08 next quarter toward $4.63 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS7 ratings
Moderate Buy
Strong Buy00%
Buy571%
Hold229%
Sell00%
Strong Sell00%
Based on 7 analysts giving stock ratings to LivaNova PLC.
As of Jul, 5 of 7 firms rate LIVN a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
LIVN EPS & revenue forecast
EPS · NEXT QUARTER
$1.08
Range $1.03 – $1.13 · 9 analysts · -3% YoY
Next period, 9 analysts expect LivaNova PLC to earn $1.08 a share (range $1.03 – $1.13), versus $1.11 a year earlier. Full-year consensus is $4.25, growing to $4.63 the year after.
REVENUE · NEXT QUARTER
$380.2M
Range $376.5M – $383.0M · 9 analysts · +6% YoY
Revenue is expected to reach $380.2M (range $376.5M – $383.0M), +6.3% year-over-year. Full-year consensus is $1.5B, rising to $1.6B next year.
Top analysts covering LivaNova PLC
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on LIVN.
#1
Mike Matson
Needham · Rank #204
Buy
$81.00-1.3% to target
Overall win rate
31%
+ Follow
#2
Matt Miksic
Barclays
Hold
$76.00-7.4% to target
Coverage
—
+ Follow
#3
Anthony Petrone
Mizuho
Buy
$95.00+15.8% to target
Coverage
—
+ Follow
#4
DR
David Rescott
Baird
Buy
$76.00-7.4% to target
Coverage
—
+ Follow
#5
Brett Fishbin
KeyBanc
Buy
$92.00+12.1% to target
Coverage
—
+ Follow
LIVN stock forecast FAQ
What is LIVN's average 12-month price target?+
The 7 analysts with a live target average $81.57 for LivaNova PLC over the next 12 months, ranging from a $95.00 high to a $70.00 low.
Is LIVN stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 7 analyst ratings, 5 are Buy or Strong Buy, 2 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for LIVN?+
The Street-high target is $95.00 (Mizuho), and the Street-low is $70.00 (Stifel). The average of all 7 active targets is $81.57.
How many Wall Street analysts cover LIVN?+
7 analysts have an active rating on LivaNova PLC, and 7 firms carry a live 12-month price target.
Who is the most accurate analyst covering LIVN?+
Among analysts who currently cover LIVN, Mike Matson of Needham has the strongest overall Quantellect track record (Rank #204). Their current call is Buy with a $81.00 target.
What is LivaNova PLC's projected EPS for next quarter?+
The consensus estimate is $1.08 per share (range $1.03 – $1.13) across 9 analysts. Full-year EPS is projected at $4.25, rising to $4.63 the following year.
How much revenue is LivaNova PLC expected to report next quarter?+
Consensus revenue is $380.2M (range $376.5M – $383.0M). Full-year revenue is projected at $1.5B, growing to $1.6B next year.
Have analysts been upgrading or downgrading LIVN lately?+
As of Jul, 5 of 7 firms rate LIVN a Buy (2 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their LIVN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
